Image Trademark with Serial Number 87417104
Status: 700 - Registered
Image for trademark with serial number 87417104
Serial Number
87417104
Registration Number
5451145
Status
700 - Registered
Status Date
2018-04-24
Filing Date
2017-04-19
Registration Number
5451145
Registration Date
2018-04-24
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s) Typeset
Design Searches
260102, 260115, 260121 - Plain single line circles. Three circles. Circles that are totally or partially shaded.
Published for Opposition Date
2018-02-06
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
SEVERSON, KAREN PATRIC
Statements
Indication of Colors claimed
The color(s) green is/are claimed as a feature of the mark.
Description of Mark
The mark consists of three circles in a triangular position. The bottom left circle is shaded green, the top left circle is outlined with a thin green outer band and the top right circle is outlined with a thick green outer band. The white in the drawing represents background and/or transparent areas and is not part of the mark.
Goods and Services
Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor- related diseases, auto-immune diseases, hormone- deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes for the treatment of rheumatoid arthritis, cancer, inflammations, transplant rejection, autoimmune diseases, autoimmune disorders, infectious diseases; biotechnological preparations for medical purposes for the treatment of rheumatoid arthritis, cancer, inflammations, transplant rejection, autoimmune diseases, autoimmune disorders, infectious diseases; pharmaceuticals for the treatment of rheumatoid arthritis, cancer, inflammations, transplant rejection, autoimmune diseases, autoimmune disorders, infectious diseases, tuberculosis, HIV/AIDS, neurological disorders, urge incontinence, neurogenic detrusor overactivity; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations for the treatment of tuberculosis, HIV/AIDS, neurological disorders, urge incontinence, neurogenic detrusor overactivity
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-04-25
Primary Code
005
Current Trademark Owners
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DAN S. COHN
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration3936765
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
South KoreaFalse
South KoreaFalse
Trademark Events
Event DateEvent Description
2017-04-22NEW APPLICATION ENTERED IN TRAM
2017-04-25NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-04-26NOTICE OF DESIGN SEARCH CODE E-MAILED
2017-06-08ASSIGNED TO EXAMINER
2017-06-12ASSIGNED TO LIE
2017-06-12DATA MODIFICATION COMPLETED
2017-06-14NON-FINAL ACTION WRITTEN
2017-06-14NON-FINAL ACTION E-MAILED
2017-06-14NOTIFICATION OF NON-FINAL ACTION E-MAILED
2017-12-07TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-12-07CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-12-07TEAS/EMAIL CORRESPONDENCE ENTERED
2017-12-28APPROVED FOR PUB - PRINCIPAL REGISTER
2018-01-17NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-02-06PUBLISHED FOR OPPOSITION
2018-02-06OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-04-24REGISTERED-PRINCIPAL REGISTER
2021-05-26AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP